AMSTERDAM and DUBAI, United Arab Emirates, Nov 14 (Bernama-GLOBE NEWSWIRE) — DEBx Medical, an Amsterdam-based pioneering innovator in the field of advanced wound care, announces the successful completion of its second capital investment round led by TVM Capital Healthcare. The funding will accelerate DEBx Medical’s global expansion into major markets around the world.
The investment follows a successful initial round of funding and reflects growing confidence in DEBx Medical’s innovative approach to chronic wound management, specifically through its breakthrough solution, DEBRICHEM®, a topical desiccating agent used to eradicate biofilm and infection from chronic wounds.